Navigation Links
SpideRX® Embolic Protection Device

ProductsSpideRX® Embolic Protection Device
Company ev3, Inc.
Item SpideRX® Embolic Protection Device
Features 
  • Pre-Loaded Filter/Capture Wire - Ready to flush and deploy with no stylet or introducer needed
  • Fully Rapid Exchange - For quick delivery and recovery
  • 6 Fr Guide Catheter Compatible (minimum 0.066" I.D.) - To use with desired interventional devices
  • Use of Separate Preferred 0.014" - 0.018" Guidewire - Reliable access and tight lesion crossing in straight and tortuous anatomy
  • Single Dual-Ended Low-Profile Catheter - Fewer components to manage during procedure
  • Low 3.2 Fr Crossing profile - Minimal interaction with the lesion during catheter placement
  • Unique Nitinol Filter Design - Provides full body wall apposition, and the ability to capture debris
  • Multiple Filter Sizes (3.0, 4.0, 5.0, 6.0, 7.0 mm) - Optimal matching of the filter to the vessel size
  • Longitudinal/Rotational Wire Movement - Filter designed to remain stationary during the intervention and device exchanges
  • Radiopaque Gold Proximal Marker - Visualization of filter apposition throughout intervention
  • 4.2 Fr Recovery Catheter - Easily accommodates filter with debris
  • Rapid Exchange Recovery Catheter - For easy recovery after intervention
Description The SpideRX Embolic Protection Device features the ability to use a separate, preferred guidewire to cross the lesion and a pre-loaded nitinol filter with a dual-ended catheter for delivery and recovery. Offering a fully rapid exchange system, the SpideRX Device is easy to use in the indicated applications:

Carotid Indication - The SpideRX Embolic Protection Device is indicated for use as a guidewire and embolic protection system to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of filter basket placement should be between 3.0 mm and 7.0 mm.

SVG Indication - The SpideRX Embolic Protection Device is indicated for use as an embolic protection system to contain and remove embolic material (thrombus/debris). The device also acts as the guidewire while performing percutaneous transluminal coronary angioplasty or stenting procedures in coronary saphenous vein bypass grafts with reference vessel diameters of 3.0 to 6.0 mm. The safety and effectiveness of this device as an embolic protection system has not been established in the cerebral and peripheral vasculature.

Info ev3, Inc.
Customer Service: (800) 716-6700
Web site: http://www.ev3.net

Related medicine products :

1. Proxis Embolic Protection System
2. FilterWire EZ Embolic Protection System
3. RX ACCUNET Embolic Protection System
4. Emboshield(R) Embolic Protection System
5. Emboshield BareWire Embolic Protection System
6. Onyx® Liquid Embolic System
7. BD Visitec Eye Protection Products
8. T4 Personal Protection System
9. Qualcraft™ Lead-Free Back-Aid Radiation Protection Apron
10. QualCraft™ Radiation Protection Eyewear -- Metal
11. Radiation Protection Eyewear
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:1/19/2017)... ... January 19, 2017 , ... ... which provides a modern CTMS workflow designed to seamlessly integrate and streamline the ... condensed to a single page, maximizing usability and improving efficiency significantly for users ...
(Date:1/19/2017)... ... January 19, 2017 , ... Ultimate ... in 2017 who are passionate about making a difference in the lives of ... in Tampa, UMA, a nonprofit healthcare educational institution, has more than 30,000 alumni ...
(Date:1/19/2017)... NJ (PRWEB) , ... January 19, 2017 , ... ... locally owned insurance agency which serves Lawrenceville, New Jersey and the surrounding area, ... , Amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that ... a rain storm by slowing down and increasing the space between themselves and other ... Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or shine, drivers ...
(Date:1/19/2017)... ... January 19, 2017 , ... "ProParagraph Basics is a set ... process for all media productions," said Christina Austin - CEO of Pixel Film ... self-animating paragraphs designed for multi-lined text purposes. Choose from presets with basic, ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
(Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements since 2010 ... agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry ... provides understanding and access to the partnering deals and ... The report provides an analysis of partnering deals. ...
(Date:1/19/2017)... ALEXANDRIA, Va. , Jan. 18, 2017 /PRNewswire/ ... commends the Food and Drug Administration (FDA) for ... biopharmaceutical companies and population health decision makers can ... FDA approved products as well as emerging therapies ... guidance largely mirrors consensus recommendations that AMCP developed ...
Breaking Medicine Technology: